JIANG ZHONG PHARMACEUTICAL CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.07 CNY | +0.89% |
|
-0.04% | +24.86% |
| 26/04 | Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 25/03 | Jiang Zhong Pharmaceutical Co.,Ltd Proposes Cash Dividend | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jiang Zhong Pharmaceutical Co Ltd is a China-based company mainly engaged in the pharmaceutical manufacturing industry. The Company's products are classified into over-the-counter drugs, prescription drugs, big health products and others, covering the fields of spleen and stomach, intestines, throat, tonic, rehabilitation nutrition, high-end tonic, cardiovascular and cerebrovascular, gynecology, urinary system and others OTC products include Jianweixiaoshi Tablets, Lactobacillus Tablets, Compound Coral Grass Tablets, and Bifidobacterium Triple Live Enteric Capsules. Health products mainly include peptides and protein powder products. Prescription drug products include Chinese medicine products such as Bazhen Yimu Capsules, Shenbao Capsules, Paishi Granules, Huangqi Shengmai Yin, Zhenju Jiangya Tablets, Shuangju Granules, Zhikang Tablets, Shuxiong Granules and others
Sector
Pharmaceuticals
Calendar
23/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
26.07
CNY
Average target price
31.12
CNY
Spread / Average Target
+19.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.86% | 2.24B | |
| +40.73% | 739B | |
| +31.13% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.02% | 240B | |
| +9.49% | 210B | |
| -5.15% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 600750 Stock
- News Jiang Zhong Pharmaceutical Co.,Ltd
- Jiangzhong Pharma Sees 26% Growth in H1 Profit
